New drug found to effectively fight latent TBSeptember 13th, 2008 - 2:57 pm ICT by ANI
Washington, Sept 13 (ANI): A new study by an Indian-origin scientist has shown that an investigative drug, called R207910, can effectively fight against latent bacteria that causes tuberculosis (TB).
R207910 is currently in clinical trials against multi-drug resistant tuberculosis strains, and scientists are hoping that it may now lead to improved and shortened treatments for this globally prevalent disease.
It is estimated that one third of the world population is infected, asymptomatically, with latent TB and is at risk of developing active TB disease during their life time.
In the new study, Anil Koul and colleagues at Johnson & Johnson, tested R207910 on dormant M. tuberculosis in three different laboratory models of latency. R207910 targets a protein (ATP synthase) essential for making cellular energy (ATP) in actively replicating TB.
According to the scientists, even dormant bacteria, which are usually physiologically “turned off”, still need to produce small quantities of ATP to survive. Already, a block in ATP synthesis can be considered an Achilles heel for killing dormant bacteria.
This reasoning proved to be correct and R207190 could successfully destroy dormant bacteria by greater than 95 percent, while current drugs like isoniazid showed no effect.
To their surprise, they found that R207910 is slightly more effective in killing dormant bacteria as compared to actively replicating ones, a unique spin as all known TB drugs are more effective on replicating bugs.
Now, researchers hope to validate these results clinically, and note that ATP synthase should be looked at as a drug target for other persistent bacterial infections. (ANI)
- Study shows experimental immune-boosting drug worsens TB in mice - Apr 13, 2010
- New test can quickly distinguish infection from tuberculosis disease - Apr 02, 2011
- New findings on drug tolerance could help cure TB faster - Mar 04, 2011
- Study sheds light on metabolic vulnerability in TB and potential drug target - May 11, 2010
- Tuberculosis enzyme responsible for lung destruction identified - Apr 26, 2011
- Awareness programmes mark World Tuberculosis Day in Delhi - Mar 24, 2011
- Should tuberculosis (TB)-preventive therapy (IPT) be given to all? - Aug 02, 2010
- New vaccine strategy tested in mice shows promise against TB - Jan 26, 2011
- 'Time to scale up work on TB control' - Jan 24, 2012
- New technique to diagnose tuberculosis sooner - May 17, 2010
- Scientists uncover new anti-TB compounds - Sep 17, 2009
- New test top diagnoseTB proves effective, convenient - Sep 02, 2010
- Regulatory Conference Shows The Way Forward From Lessons Learnt In The Past - Aug 20, 2010
- Priority is to up collaborative TB-HIV activities - Jul 19, 2010
- Berlin 2010: TB, HIV and Lung Health: From research and innovation to solutions - Nov 02, 2010
Tags: achilles heel, atp synthase, atp synthesis, cellular energy, drug resistant tuberculosis, drug target, indian origin, isoniazid, koul, laboratory models, latent tb, multi drug resistant tuberculosis, persistent bacterial infections, prevalent disease, r207910, small quantities, tb disease, tb drugs, tuberculosis tb, world population